» Articles » PMID: 22130802

Neonatal Screening for Severe Primary Immunodeficiency Diseases Using High-throughput Triplex Real-time PCR

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2011 Dec 2
PMID 22130802
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Severe combined immunodeficiency (SCID) and X-linked agammaglobulinemia (XLA) are inborn errors of immune function that require prompt diagnosis and treatment to prevent life-threatening infections. The lack of functional T or B lymphocytes in these diseases serves as a diagnostic criterion and can be applied to neonatal screening. A robust triplex PCR method for quantitation of T-cell receptor excision circles (TRECs) and κ-deleting recombination excision circles (KRECs), using a single Guthrie card punch, was developed and validated in a cohort of 2560 anonymized newborn screening cards and in 49 original stored Guthrie cards from patients diagnosed with SCID, XLA, ataxia-telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A deficiency, or X-linked hyper-IgM syndrome. Simultaneous measurement of TREC and KREC copy numbers in Guthrie card samples readily identified patients with SCID, XLA, ataxia-telangiectasia and Nijmegen-breakage-syndrome and thus facilitates effective newborn screening for severe immunodeficiency syndromes characterized by the absence of T or B cells.

Citing Articles

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn Screening.

Bzdok J, Czibere L, Burggraf S, Pauly N, Maier E, Roschinger W Genes (Basel). 2024; 15(11).

PMID: 39596667 PMC: 11593867. DOI: 10.3390/genes15111467.


Newborn screening for SCID: the very first prospective pilot study from Türkiye.

Haskologlu S, Kocak S, Tufan L, Aksoy F, Bastug D, Oner D Front Immunol. 2024; 15:1384195.

PMID: 39483481 PMC: 11526446. DOI: 10.3389/fimmu.2024.1384195.


A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.

Shibata H, Nakajima D, Konno R, Hijikata A, Higashiguchi M, Nihira H J Clin Immunol. 2024; 45(1):33.

PMID: 39453496 PMC: 11511704. DOI: 10.1007/s10875-024-01821-7.


Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia.

Kumarasamy G, Khairiz K, Chang W, Aye T, Ali A Front Immunol. 2024; 15:1400247.

PMID: 38983864 PMC: 11231083. DOI: 10.3389/fimmu.2024.1400247.


Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy.

Bzdok J, Czibere L, Burggraf S, Landt O, Maier E, Roschinger W PLoS One. 2024; 19(6):e0306329.

PMID: 38941330 PMC: 11213327. DOI: 10.1371/journal.pone.0306329.